Danaher Corporation/ US2358511028 /
20/09/2024 22:10:00 | Chg. -3.80 | Volume | Bid00:44:03 | Ask00:44:03 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
272.63USD | -1.37% | 9.27 mill. Turnover: 1.83 bill. |
271.80Bid Size: 100 | 273.37Ask Size: 100 | 196.9 bill.USD | 0.39% | 42.33 |
GlobeNewswire
20/08
Intelligent Product Solutions Announces that Brad Carlson Joins as VP of Technology and Business Dev...
GlobeNewswire
08/03
Resilinc CEO Honored With a 2024 Pros to Know Lifetime Achievement Award from Supply & Demand Chain ...
GlobeNewswire
26/02
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
29/01
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
13/12/2023
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
GlobeNewswire
15/11/2023
Brady Corporation elects Board of Directors and declares regular dividend to shareholders
GlobeNewswire
14/11/2023
Lincoln Electric Appoints J. Ashley Hall as Senior Vice President, Global Procurement
GlobeNewswire
01/11/2023
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
GlobeNewswire
16/10/2023
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher...
GlobeNewswire
12/10/2023
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire
08/10/2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPT, HT, ABCM, AGE
GlobeNewswire
02/10/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer